IXICO plc
PHYOF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | – | $3 | $3 | $3 |
| % Growth | – | -0.6% | 27.2% | – |
| Cost of Goods Sold | – | $2 | $2 | $2 |
| Gross Profit | – | $2 | $2 | $1 |
| % Margin | – | 49.6% | 48.4% | 40.2% |
| R&D Expenses | – | $1 | $1 | $1 |
| G&A Expenses | – | $1 | $0 | $1 |
| SG&A Expenses | – | $2 | $2 | $2 |
| Sales & Mktg Exp. | – | $1 | $0 | $1 |
| Other Operating Expenses | – | -$0 | $0 | -$0 |
| Operating Expenses | – | $3 | $3 | $3 |
| Operating Income | – | -$1 | -$1 | -$2 |
| % Margin | – | -29% | -33.8% | -62.6% |
| Other Income/Exp. Net | – | $0 | $1 | $0 |
| Pre-Tax Income | – | -$1 | -$1 | -$2 |
| Tax Expense | – | $0 | $0 | -$0 |
| Net Income | – | -$1 | -$1 | -$1 |
| % Margin | – | -29.9% | -18.2% | -55.7% |
| EPS | – | -0.011 | -0.012 | -0.029 |
| % Growth | – | 9% | 58.2% | – |
| EPS Diluted | – | -0.011 | -0.012 | -0.029 |
| Weighted Avg Shares Out | – | 86 | 48 | 48 |
| Weighted Avg Shares Out Dil | – | 86 | 48 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | -$1 | -$0 | -$1 |
| % Margin | – | -22.5% | -9.4% | -53.1% |